Summary. The effect of biguanides on substrate metabolism of muscle was studied by measurement of arterial and deep venous concentrations of glucose, lactate pyruvate and oxygen and of forearm blood flow in 6 maturity onset diabetics before and after five days of oral phenformin (150 mg/day).
Biguanides may be assumed to exhibit their blood glucose lowering effect via diminished glucose absorption from the gut [1, 2] and reduced hepatic glucose production, at least in part through limited precursor-induced acceleration of gluconeogenesis [3] [4] [5] [6] [7] [8] [9] [10] [11] . This latter action is one of the factors which favour the accumulation of blood lactate [11] . Conflicting results, however, have been obtained on peripheral glucose oxidation [12, 13] in relation to the development of lactic acidosis during biguanide treatment. Using the forearm method decreased lactate release by resting muscle was found in healthy volunteers [14] ; in contrast, in vitro studies showed increased muscle lactate output [15] [16] [17] [18] . Similarly, peripheral glucose uptake which was found to be lessened in healthy man [14] , was unchanged [19] or increased [20] in maturity onset diabetics. These contradictory data may have been partly due to different experimental techniques and methods of biguanide administration.
One possibility is that biguanides act through inhibition of oxidative phosphorylation [15, 21] . We have therefore investigated their effect on muscle metabolism during work, when energy demand is high and increased substrate oxidation is essential.
Material and Methods

Subjects
Six maturity-onset diabetics were recruited from hospitalized patients of the 3 rd Medical Department of the Schwabing City Hospital. All were informed about the aim and the risks of the study and gave their consent. The protocol for this study was reviewed and approved by the Investigation-and Ethical-Committee of the Sonderforschungsbereich 51 of the Deutsche Forschungsgemeinschaft according to the code of ethics of the World Medical Association [22] .
0012-186X/78/0015/0099/$01.20 Table  1 . Physical examination as well as laboratory tests performed in the Department of Clinical Chemistry of the Schwabing City Hospital excluded other internal diseases, though patients B.E. and H.E. had coronary heart disease and were receiving treatment with digitalis, spironolactone and isosorbitol dinitrate. The other patients were on no drugs besides their antidiabetic therapy. There were no gross lipid disturbances except in patient R. K.
Diabetes was treated with a dietary regimen and, when necessary, with sulphonylureas for one week at the dose used before admission. The first measurement of muscle metabolism was performed after an overnight fast, 24 hours after the last oral antidiabetic therapy. Patients received no premeditation. Thereafter, in addition to the previous antidiabetic treatment 50 mg of phenformin (Dipar | Boehringer Mannheim, FRG) were given three times daily for 5 days and the second study of muscle metabolism performed. Again, treatment with sulphonylureas was withheld for 24 h, but phenformin treatment was continued and 50 mg were given 1-2 h prior to the test.
During the course of diagnostic blood sampling muscle substrate balances were obtained from one diabetic suffering from lactic acidosis (R. E., Table 1 ) who had been treated for two years with diet and 100 mg phenformin daily. Besides 2 • 1 tablets Modenol | (Boehringer Mannheim, FRG, one tablet containing 3.3 mg butizide, 0.07 mg reserpine, 0.07 mg rescinnamine, 0.7 mg raubasine and 300 mg potassium chloride) for hypertension and 3 • 0.125 nag digoxin for myocardial failure per day no other drugs had been given to the patient. A few days before admission the patient developed increasing gastric and intestinal discomfort, vomitus and fatigue. On admmission she was comatose and was not in manifest heart failure. The diagnosis of lactic acidosis was confirmed by an arterial lactate level of 14.8 mmol/1 and blood pH of 6.96. The level of haemoglobin was 13.1 g/100 ml. Further details have been published elsewhere [23] .
Catheterization, Blood Sampling and Measurement of Forearm Muscle Blood Flow
All studies were performed between 8.30 a. m. and 11.30a. m. with the subjects recumbent. Special care was taken to ensure that the arm rested comfortably in a horizontal position and that room temperature remained constant. Under sterile conditions and local anaesthesia a Cournand-needle (Size: PE 160, Kifa, Sweden) was inserted into the right femoral artery, and flushed continuously with NaCI (0.154 mol/l) containing small amounts of heparin at a rate (0.05 U/kg body weight x min) which guaranteed no significant effect on lipoprotein lipase activity [24] . Thereafter, one of the cubital veins probably draining deep tissues of the forearm was cannulated and a teflon catheter (Code 11512, Vygon, France) inserted as deeply as possible, i.e. when the tip of the catheter could no longer be palpated, X-ray examination confirmed a position in deep forearm tissue and the arterial-deep venous oxygen difference exceeded 2.5 mmol/I. Special care was taken that during the second experiment the same position was obtained as during the first study. After an equilibration period of 15 minutes arterial and deep venous blood samples were taken at 10 minute intervals during a 30 min basal period and at 30 second intervals during an one minute half-maximal rhythmic handgrip work (5 kpm/min), standardized by a special ergometer [25] , and at 1.3 and 5 minutes during recovery.
Immediately after sampling 2 ml of blood were mixed with 6 ml of icecold 0.6 mol/l perchloric acid and centrifuged at 4 ~ After neutralization with KHCO3 the supernatants were analyzed as quickly as possible for pyruvate. Glucose, lactate and alanine were determined after storage overnight at -20 ~ Blood samples for oxygen were taken in heparinized syringes and analyzed immediately.
Forearm blood flow was measured during the basal period by venous occlusion plethysmography [26] and, additionally, during the basal period, exercise and recovery by the 133Xenon injection technique [27] .
In the case of the lactic acidosis patient only two arterial and deep-venous blood samples were taken at a 2 minute interval and 9 blood flow of the forearm was measured by venous occlusion technique before any therapy was started. The commencement of therapy was not delayed, since this procedure was finished within 5-10 rain. During this time a central venous catheter was inserted from the other arm and therapy was started immediately after the second blood sample. Blood pressure was found to be 110/80 mm Hg when blood samples were obtained.
Analyses
Glucose, lactate, pyruvate and alanine were determined enzymatically [28-3 i] , and oxygen was determined oxyrnetrically [32] . Precision of the methods has been given elsewhere [33] . Substrates in each blood sample were determined at least in duplicate. The basal values represent the mean of four determinations obtained at 10 minute intervals before exercise was started. Wilcoxon's rank test was applied to the results [34] . A significant difference was assumed at p < 0.05. All mean values are given with the standard error of the mean (SEM). Substrate uptake was calculated according to Fick [35] by multiplying the blood flow rates obtained with the 133-Xenon-technique during basal period, exercise and recovery with the corresponding arterial-deep-venous substrate differences.
Materials
Radioactive 133Xenon (Radiochemical Centre, Amersham, Great Britain) was purchased as a sterile solution of 2 Ci/cm 3. Heparin was used as a sterile solution of sodium heparinate containing 5000 USP U/ml (Hoffmann-La Roche, Grenzach, FRG). (Table 2) : As expected in maturity-onset diabetics arterial glucose concentration was significantly decreased with phenformin therapy compared to pretreatment values. Alanine concentration was found to be elevated with phenformin. The arterial levels of lactate, pyruvate and oxygen remained unchanged after phenformin treatment.
Results
Effect of Phenformin Treatment on Arterial Concentrations and Balances of Substrates a) At Rest
No significant changes were found for the arterial-deep venous differences of glucose, lactate, pyrurate, alanine and oxygen. Plethysmography showed no effect of phenformin on the rate of blood flow of the forearm. (Tables 3  and 4) : During the short period of work (1 rain) and during recovery (5 min) the arterial concentrations of oxygen and of the substrates remained constant.
b) During Muscular Work and Recovery
During rhythmic forearm exercise the same increase of muscular blood flow was obtained using the 133xenon-injection-technique with and without phenformin. During recovery, blood flow also decreased to the same extent. Since blood flow was not influenced by phenformin, the observed differences in substrate utilisation (Table 4) were exclusively due to the changed balances, which are indicated in Table 3 . The values represent the mean • SEM of 6 subjects in ammol/1 and in bml/100 g . min (Measured by venous occlusion plethysmography). For each subject 4 samples obtained at 10 min intervals were averaged. c Significant difference after phenformin compared with untreated (p < 0.05, according to rank order) -: Indicates release Table 3 . Arterial-deep venous differences of glucose, lactate, pyruvate and oxygen, muscle blood flow and deep-venous lactate/pyruvate ratio in maturity onset diabetics before (U) and after treatment (P) with phenforrnin during rhythmic isometric forearm exercise (1 min) and during recovery (5 min) The values represent the mean + SEM of 6 subjects in ~tmol per 100 g of muscle weight per minute. Blood flow was measured with the 133Xenon injection technique. During the basal period for each subject four samples obtained at 10 rain intervals were averaged and used for calculation. a Significant difference after phenformin compared with untreated (p < 0.05, according to rank order) --: Indicates release
Before treatment, glucose release during rest was significantly increased during work, and returned continuously to basal during recovery. After treatment with phenformin, glucose uptake was observed during work rather than glucose release. This continued during recovery. Lactate production was increased likewise with and without pretreatment during muscle work. However, during recovery after treatment, this increased lactate output returned more gradually towards normal. On the contrary, pyruvate output decreased more rapidly after phenformin. Accordingly, the deep venous L/P-ratio, which before treatment increased during muscular work and decreased continuously during recovery, showed a much greater increase during work after phenformin and remained elevated during recovery.
Before treatment, no difference in muscle oxygen uptake from basal values was observed during the recovery phase. However, after phenformin treatment oxygen uptake was found to be elevated during recovery.
Substrate Balances of the Resting Muscle in One Case of Fatal Lactic Acidosis
In patient R.E. (Table 1) , arterial lactate was 14.8 mmol/1 and pyruvate 0.19 mmol/1. Immediately before therapy, arterial-deep venous balances for lactate were -0.95 and for pyruvate -0.13mmol/1. The perfusion of the forearm was 2.2 ml/100 g -min as obtained by venous occlusion plethysmography. For comparison, the corresponding normal values in maturity onset diabetics are listed up in Table 2 .
Discussion
In the present study five days pretreatment with phenformin was employed since it has become evident that this regimen leads to cellular concentrations similar to those effective in vitro [36, 37] . Nevertheless, no significant changes of glucose utilization and C3-body production of the muscle were observed during resting conditions (Table 2 ). However, since the same amount of glucose was taken up at a lower arterial concentration, an increased fractional extraction of glucose was obvious. This finding corresponds to earlier results [38] demonstrating that biguanides lower the threshold for glucose entry into the muscle cell. Biguanides are known to accelerate glycogenolysis [18] . While, in general, glycogen stores are reduced during muscular work and are restored again during rest, one would expect under biguanide treatment that depletion of the glycogen stores would be more intensive and restoration slowlier. Since changes in the rate of glycogenolysis may effect glucose uptake of muscle [39] [40] [41] [42] one would also expect to find, with biguanides, corresponding to the overwhelming of glycogen breakdown or synthesis, either reduced glucose uptake, as was found in healthy volunteers [14] , or enhanced glucose uptake as was found in the diabetic state [20, 38] , when glycogen stores are more rapidly depleted [43] . According to these findings one might suggest that the increased fractional extraction of glucose by muscle found in this study could also be due to a prolonged restoration of the glycogen stores caused by the preceding depletion. Since there were no enzymes found to be influenced by biguanides [7] acceleration of glycogenolysis was suggested to be due to the wellknown inhibitory action of the biguanides on electron transport and oxidative phosphorylation [15, 21] . If this were also true in the model presented, a greater portion of the glucose taken up should leave the muscle again as lactate. This was not the case under resting conditions. Since decreased availability of glucose from depleted glycogen stores and inhibition of elec-tron transport should become more obvious when energy demand rises, we have employed short and mild muscular exercise. Indeed, this procedure, which reduced glucose uptake in normal [44] and exhibited even glucose output in diabetic subjects (Table 3) , resulted in acceleration of glucose entry under the influence of phenformin. From the data presented here it is difficult to decide whether this effect is due to decreased intracellular availability of glucose or to impaired electron transport. The unchanged rates of lactate output during work support the first possibility. However, one has to take into account that lactate usually accumulates within the muscle until its production rates are found to be increased [45, 46] . This could play a role, since work was short and mild and lactate production was indeed larger during recovery. Furthermore, increased deep venous lactate/pyruvate ratio and oxygen consumption during recovery would also support the view that a greater energy lack during work is also at least partly responsible for the accelerated glucose uptake observed. This view receives support from results obtained with the isolated hind limb, which show greater reduction of the creatine phosphate content during work after phenformin pretreatment [47] .
From these findings one can conclude that the effect of biguanides on muscle glucose uptake and consequently on blood glucose concentration may not entirely be unconnected with increased production of lactate. Taking into account that there is also impaired hepatic lactate uptake under biguanide treatment [10, 11] one may expect disturbance of lactate homeostasis at least under certain conditions leading to accelerated lactate production. That enhanced peripheral production of lactate may be one of the factors which are responsible for the occurrence of fatal lactic acidosis is underlined by the increased rates of muscle lactate output obtained in one case suffering from this complication (see Results 2) .
